Adriamycin Rdf



Indications and Reactions:

Role Indications Reactions
Primary
Breast Cancer 39.4%
B-cell Lymphoma Stage Iii 24.2%
Lymphoma 15.2%
Hodgkin's Disease 12.1%
Prophylaxis 6.1%
Breast Cancer Metastatic 3.0%
Febrile Neutropenia 23.1%
Lung Disorder 15.4%
Staphylococcal Infection 15.4%
Cardiac Failure Congestive 7.7%
Pancytopenia 7.7%
Pulmonary Toxicity 7.7%
Tongue Disorder 7.7%
Vomiting 7.7%
White Blood Cell Count Decreased 7.7%
Secondary
Breast Cancer 19.9%
Drug Use For Unknown Indication 17.4%
Multiple Myeloma 12.8%
Haematological Malignancy 12.6%
Hodgkin's Disease 5.2%
Mantle Cell Lymphoma 5.2%
Malignant Lymphoid Neoplasm 3.3%
Inflammatory Carcinoma Of The Breast 3.1%
Bone Sarcoma 2.5%
Sarcoma 2.5%
Diffuse Large B-cell Lymphoma 2.3%
Non-hodgkin's Lymphoma 2.1%
Breast Cancer Metastatic 1.9%
B-cell Lymphoma Stage Iii 1.7%
Acute Myeloid Leukaemia 1.5%
Chemotherapy 1.5%
Hepatic Mass 1.3%
Testis Cancer 1.3%
Adrenocortical Carcinoma 1.0%
B-cell Lymphoma 1.0%
Pyrexia 8.8%
Renal Failure 8.8%
Febrile Neutropenia 7.0%
Respiratory Failure 7.0%
Sepsis 7.0%
Tachycardia 7.0%
Neoplasm Recurrence 5.3%
Pneumocystis Jiroveci Pneumonia 5.3%
Vomiting 5.3%
Acute Myeloid Leukaemia 3.5%
Dyspnoea 3.5%
Extramedullary Haemopoiesis 3.5%
Leukopenia 3.5%
Lung Disorder 3.5%
Myocarditis 3.5%
Neutrophil Count Decreased 3.5%
Palmar-plantar Erythrodysaesthesia Syndrome 3.5%
Perirectal Abscess 3.5%
Proctalgia 3.5%
Progressive Multifocal Leukoencephalopathy 3.5%
Concomitant
Chemotherapy 21.2%
Drug Use For Unknown Indication 19.3%
Multiple Myeloma 17.5%
Chronic Myeloid Leukaemia 5.7%
Hypertension 4.2%
Small Cell Lung Cancer Stage Unspecified 3.8%
Oesophagitis 2.8%
Pain 2.8%
Acute Lymphocytic Leukaemia 2.4%
Diffuse Large B-cell Lymphoma 2.4%
Febrile Bone Marrow Aplasia 2.4%
Prostate Cancer Stage Iv 2.4%
Anaemia Of Malignant Disease 1.9%
Breast Cancer 1.9%
Diabetes Mellitus 1.9%
Non-hodgkin's Lymphoma 1.9%
B-cell Lymphoma 1.4%
Bone Disorder 1.4%
Hiv Infection 1.4%
Sarcoma 1.4%
Pyrexia 12.5%
Vomiting 12.5%
Bone Pain 7.1%
White Blood Cell Count Decreased 7.1%
Drug Ineffective 5.4%
Encephalitis 5.4%
Febrile Neutropenia 5.4%
Tooth Extraction 5.4%
Cachexia 3.6%
Osteonecrosis 3.6%
Renal Failure Chronic 3.6%
Sepsis 3.6%
Septic Shock 3.6%
Toothache 3.6%
Upper Respiratory Tract Infection 3.6%
Urticaria 3.6%
White Blood Cell Count Increased 3.6%
Wound Secretion 3.6%
Anaphylactic Reaction 1.8%
Arthralgia 1.8%